Picture of Scandinavian ChemoTech AB logo

CMOTEC B Scandinavian ChemoTech AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Scandinavian ChemoTech: Case Series Study

Sept 16 (Reuters) - Scandinavian ChemoTech AB  CMOTECb.ST :
    * SAID ON THURSDAY CASE SERIES STUDY INDICATES TSE CAN BE
PERFORMED WITHOUT GENERAL ANAESTHESIA
    * STUDY INCLUDED COHORT OF 21 PATIENTS WHO RECEIVED TSE
THERAPY
UNDER SEDATION AND PAIN RELIEF

Source text for Eikon:  ID:nWkr6KhMYg 
Further company coverage:  CMOTECb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Scandinavian ChemoTech AB

See all news